Suppr超能文献

基于 CRISPR/Cas 的检测方法进行下一代病原体诊断。

Next-generation pathogen diagnosis with CRISPR/Cas-based detection methods.

机构信息

Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai, People's Republic of China.

Suzhou Maximum Bio-tech Co., Ltd., Suzhou, People's Republic of China.

出版信息

Emerg Microbes Infect. 2020 Dec;9(1):1682-1691. doi: 10.1080/22221751.2020.1793689.

Abstract

Ideal methods for detecting pathogens should be sensitive, specific, rapid, cost-effective and instrument-free. Conventional nucleic acid pathogen detection strategies, mostly PCR-based techniques, have various limitations, such as expensive equipment, reagents and skilled performance. Recently, CRISPR/Cas-based methods have burst onto the scene, with the potential to power the pathogen detection field. Here we introduce these unique methods and discuss its hurdles and promises.

摘要

理想的病原体检测方法应该具有灵敏度高、特异性强、快速、经济实惠且无需仪器的特点。传统的核酸病原体检测策略,主要是基于 PCR 的技术,存在各种局限性,如昂贵的设备、试剂和熟练的操作。最近,基于 CRISPR/Cas 的方法异军突起,有可能为病原体检测领域提供动力。在这里,我们介绍这些独特的方法,并讨论它们的障碍和前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd68/7473117/3133c793e573/TEMI_A_1793689_F0001_OC.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验